Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 373,241 | 275,875 | 140,745 | 161,900 | 186,409 |
| Marketable Securities | 188,828 | 201,642 | 209,642 | 217,271 | 208,011 |
| Receivables | 9,316 | N/A | N/A | N/A | N/A |
| Inventories | 5,278 | N/A | N/A | N/A | N/A |
| TOTAL | $582,128 | $484,004 | $355,429 | $383,779 | $397,578 |
| Non-Current Assets | |||||
| PPE Net | 164,029 | 163,737 | 163,073 | 161,684 | 157,786 |
| Investments And Advances | 36,548 | 28,410 | 5,129 | 4,621 | 12,557 |
| Other Non-Current Assets | 7,645 | 7,875 | 8,216 | 8,366 | 8,458 |
| TOTAL | $208,222 | $200,022 | $176,418 | $174,671 | $178,801 |
| Total Assets | $790,350 | $684,026 | $531,847 | $558,450 | $576,379 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,340 | 4,446 | 4,109 | 3,981 | 5,761 |
| Accrued Expenses | 21,742 | 17,923 | 29,414 | 23,305 | 20,724 |
| TOTAL | $27,583 | $23,898 | $35,076 | $28,847 | $28,032 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,819 | 7,014 | 7,205 | 7,372 | 7,575 |
| TOTAL | $6,819 | $7,014 | $7,205 | $7,372 | $7,575 |
| Total Liabilities | $34,402 | $30,912 | $42,281 | $36,219 | $35,607 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,206 | 27,994 | 25,800 | 25,764 | 25,748 |
| Retained earnings | -278,519 | -359,266 | -326,056 | -280,759 | -248,707 |
| Other shareholders' equity | -382 | -236 | -154 | -728 | -1,475 |
| TOTAL | $755,948 | $653,114 | $489,566 | $522,231 | $540,772 |
| Total Liabilities And Equity | $790,350 | $684,026 | $531,847 | $558,450 | $576,379 |